Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma

Conclusion: CXCR4-directed RLT (in combination with additional radioimmunotherapy) is feasible as a conditioning regimen before allogeneic stem cell transplantation in diffuse large B-cell lymphoma.

Source: Journal of Nuclear Medicine - January 2, 2019 Category: Nuclear Medicine Authors: Lapa, C., Hanscheid, H., Kircher, M., Schirbel, A., Wunderlich, G., Werner, R. A., Samnick, S., Kotzerke, J., Einsele, H., Buck, A. K., Wester, H.-J., Grigoleit, G. U. Tags: Clinical Source Type: research